Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8165163 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL8165164 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL4435261 | 0.81 | NPSR1 (0.46) | CYP2C19NPSR1ALDH1A1LMNATSHR | |
| SCHEMBL8510908 | 0.78 | FFAR3 (0.31) | FFAR3 | |
| SCHEMBL8510912 | 0.78 | FFAR3 (0.31) | FFAR3 | |
| SCHEMBL11210884 | 0.78 | CYP2C19 (0.32) | CYP2C19FFAR3 | |
| SCHEMBL21407992 | 0.74 | — | — | |
| SCHEMBL4187606 | 0.72 | CYP2C19 (0.35) | CYP2C19 | |
| SCHEMBL30640426 | 0.72 | CYP2C19 (0.35) | CYP2C19FFAR3NPSR1LMNACYP1A2 | |
| SCHEMBL9770265 | 0.72 | ALDH1A1 (0.36) | CYP2C19USP2ALDH1A1LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100215604-A1 | Cosmetic Compositions with Chitosan and Silicone Elastomers | HENKEL AG & CO. KGAA (DE) | 2010-08-26 | — | — | US | disclosed |
| US-20070292379-A1 | HAIR TREATING AGENT COMPRISING CORNEOCYTE PROTEINS OR CORNEOCYTE POLYPEPTIDES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-12-20 | — | — | US | disclosed |
| EP-0763357-A1 | Bisguanidines containing pharmaceutical compositions | Blank, Izhak (IL) | 1997-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100215604-A1 | Cosmetic Compositions with Chitosan and Silicone Elastomers | HDAC10, HDAC1, HDAC3 | CYP2C19 4197/4885FFAR3 3053/4885AKR1C1 3551/4885 |
| US-20070292379-A1 | HAIR TREATING AGENT COMPRISING CORNEOCYTE PROTEINS OR CORNEOCYTE POLYPEPTIDES | KRT18, S100A4, S100P | CYP2C19 4828/4885FFAR3 3911/4885AKR1C1 3615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.